AU vs NUE

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite robust profitability metrics—ROE of 38.71%, operating margin of 42.49%, and strong YoY earnings growth of 147.2%—the stock trades at a premium valuation with a P/E of 22.56 and Price/Book of 6.98, above sector averages. Persistent earnings misses over the last four quarters and a weak technical trend score of 10/100 suggest caution, even as analyst consensus remains at 'buy'. The current price of $106.26 sits above the Graham Number of $40.18, reflecting high growth expectations rather than defensive value.

NUE presents a dichotomy between exceptional growth and deteriorating momentum, anchored by a stable Piotroski F-Score of 4/9. While the company exhibits explosive YoY earnings growth (382.10%) and a rock-solid balance sheet (Debt/Equity 0.32), the stock is currently trading at its 52-week high ($225.29 vs $227.48) despite a severely bearish technical trend (10/100). The valuation is stretched, as evidenced by a high PEG ratio of 5.21 and a current price significantly above the Graham Number of $144.15, suggesting the market has already priced in most of the growth.